Cleveland Jewish News: William Schiemann, associate professor of general medical sciences, led a team of researchers who found a link between a micro ribonucleic acid molecule and late-stage breast cancer. “Our micro RNA inactivates [a protein called] Bim, and we think this leads to chemo resistance to these metastatic cancers,” Schiemann said. Lower Bim levels, coupled with higher miR-181a levels, allow the spread of cancer.
Medicine’s William Schiemann and researchers target molecule’s role in late-stage breast cancer
- School of Medicine expert receives two Innovation Grants in pursuit of HIV cure
- Find out how you can make the most of your retirement plan at workshops next week
- University Technology encourages Apple users to update operating systems to address security threat
- Psychological sciences’ Brooke Macnamara explains her research on practice
- History’s Kenneth Ledford talks about Donald Trump’s statement about NATO